There is good news for the men in Israel and Palestine territories. A new pharmaceutical treatment “Vitaros” will be made available over here by Apricus Biosciences. This erectile dysfunction cream will be marketed by Neopharm group. Apricus will be paid a huge amount of $4.35 million by the Neopharm group that would also include royalties.
It has been clearly stated that though it is treatment for erectile Dysfunction and is very different from the other drugs. It is not an oral medication and can be applied directly to the penis and will be absorbed quickly. Alprostadil is the name of the chief chemical in Vitaros unlike the other drugs. This chemical is said to work promptly and show quicker results than the rest.
In Israel, the application will be filed by 2011 while it will seek the Palestine areas later. It has been noticed that the sales have risen since the deal has been announced.
It was turned down in 2008 by the food and the Drug Administration in USA as they noticed that the mice who consumed the dug were suffering from Cancer. It has been seen that this is the third licensing agreement deal that it has signed since last December. As of now, this deal caters to 14 countries which is truly laudable.
David Fuhrer, chairman of the Neopharm Group is really confident that the sales would rise further in the coming years.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment